KRAS and colorectal carcinoma: Consistent with the findings of Connell et al., CRC patients with liver metastases harboring KRAS mutations exhibited elevated LDHA expression, which was associated with reduced overall survival, highlighting the prognostic relevance of LDHA in this context [30].